Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume $0.31 +0.04 (+14.94%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Aptevo Therapeutics Short Interest DataAptevo Therapeutics (APVO) has a short interest of 1.20 million shares. This marks a 675.69% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 3.79 million shares to cover all short positions.Current Short Interest1,200,000 sharesPrevious Short Interest154,700 sharesChange Vs. Previous Month+675.69%Dollar Volume Sold Short$323,880.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares18,512,000 sharesPercentage of Shares Shorted6.48%Today's Trading Volume2,039,032 sharesAverage Trading Volume3,789,282 sharesToday's Volume Vs. Average54% Short Selling Aptevo Therapeutics? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,200,000 shares $323,880.00 +675.7%N/A0.2 $0.27 10/15/2024154,700 shares $22,416.03 +164.9%N/A0 $0.14 9/30/202458,400 shares $10,500.32 +349.2%N/A0 $0.18 9/15/202413,000 shares $4,613.70 -78.8%N/A0 $0.35 8/31/202461,400 shares $22,104.00 -80.2%N/A0 $0.36 8/15/2024310,700 shares $135,154.50 -54.8%N/A0.1 $0.44 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024687,500 shares $277,268.75 +2.9%N/A0.1 $0.40 7/15/2024668,300 shares $203,965.16 +91.7%N/A0.1 $0.31 6/30/2024348,700 shares $106,702.20 +1,552.6%N/A0.4 $0.31 6/15/202421,100 shares $16,198.47 -55.8%0.5%0 $0.77 5/31/202447,700 shares $33,991.02 -11.7%1.2%0.1 $0.71 5/15/202454,000 shares $43,632.00 -79.9%1.3%0.1 $0.81 4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48 2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16 1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16 1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32 9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46 6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56 5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04 3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04 9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74 8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54 8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59 7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94 7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92 6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58 6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30 5/31/2022145,200 shares $665,016.00 +1.0%N/A0.7 $4.58 5/15/2022143,700 shares $661,020.00 -13.4%N/A0.7 $4.60 4/30/2022165,900 shares $706,734.00 -12.2%N/A0.7 $4.26 4/15/2022188,900 shares $899,164.00 -6.3%N/A0.7 $4.76 3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87 3/15/2022144,500 shares $647,360.00 +1.4%N/A1 $4.48 2/28/2022142,500 shares $820,800.00 -19.4%N/A0.6 $5.76 2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29 1/31/202250,900 shares $297,256.00 -65.8%N/A0 $5.84 1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22 12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87 12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90 11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96 11/15/202187,300 shares $848,556.00 +4.9%N/A0 $9.72 10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24 10/15/202162,900 shares $942,871.00 +4.7%N/A1.4 $14.99 9/30/202160,100 shares $927,944.00 -6.1%N/A1.2 $15.44 9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14 8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95 8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00 7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77 7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75 6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43 6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00 5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12 5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93 4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34 4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57 3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20 3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97 2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62 2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83 1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82 12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11 12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61 11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39 11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98 10/30/202086,900 shares $572,671.00 +2.4%3.0%0.1 $6.59 10/15/202084,900 shares $594,300.00 -15.1%3.0%1.6 $7.00 9/30/2020100,000 shares $760,000.00 +33.7%3.5%1.2 $7.60 9/15/202074,800 shares $596,156.00 +9.2%2.6%0.1 $7.97 8/31/202068,500 shares $537,040.00 -20.3%2.4%0.1 $7.84 8/14/202085,900 shares $684,623.00 +39.7%3.0%0.1 $7.97 7/31/202061,500 shares $516,600.00 +27.6%2.1%0.1 $8.40 7/15/202048,200 shares $352,342.00 -75.1%1.7%0.1 $7.31 6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35 6/15/202078,200 shares $420,716.00 -0.4%2.7%0.8 $5.38 5/29/202078,500 shares $466,290.00 -3.8%2.7%0.6 $5.94 5/15/202081,600 shares $446,352.00 +54.0%2.8%0.6 $5.47 4/30/202053,000 shares $265,000.00 -8.5%1.8%0.4 $5.00 4/15/202057,900 shares $242,022.00 +2.1%2.0%0.7 $4.18 3/31/202056,700 shares $242,676.00 -93.8%2.0%0.7 $4.28 3/13/2020918,900 shares $3.53 million -44.3%2.3%0.3 $3.84 2/28/20201,650,000 shares $429,000.00 +36.4%4.1%2.8 $0.26 2/14/20201,210,000 shares $435,600.00 +10.0%3.0%2.9 $0.36 1/31/20201,100,000 shares $484,000.00 -26.7%2.7%2.9 $0.44 1/15/20201,500,000 shares $765,000.00 -10.7%3.7%4.1 $0.51 12/31/20191,680,000 shares $1.08 million -2.9%4.2%4.7 $0.64 APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 1,200,000 shares of APVO short. Learn More on Aptevo Therapeutics' current short interest. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 1,200,000 shares, an increase of 675.7% from the previous total of 154,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aptevo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Unity Biotechnology, Inc. (1.97%), MEI Pharma, Inc. (1.23%), ProPhase Labs, Inc. (0.65%), Enlivex Therapeutics Ltd. (0.75%), Cognition Therapeutics, Inc. (2.41%), Marinus Pharmaceuticals, Inc. (10.26%), Bullfrog AI Holdings, Inc. (4.76%), Flora Growth Corp. (9.66%), Cara Therapeutics, Inc. (2.06%), Tenax Therapeutics, Inc. (3.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies UBX Short Interest Data MEIP Short Interest Data PRPH Short Interest Data ENLV Short Interest Data CGTX Short Interest Data MRNS Short Interest Data BFRG Short Interest Data FLGC Short Interest Data CARA Short Interest Data TENX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APVO Stock Alerts